Market Size & Trends
The U.S. continuous positive airway pressure devices market size was valued at USD 632.10 million in 2024 and is expected to grow at a CAGR of 4.44% from 2025 to 2030. This is attributed to the rising prevalence of sleep apnea and respiratory disorders, technological advancements in continuous positive airway pressure (CPAP) devices, growing awareness and diagnosis of sleep apnea, and favorable reimbursement policies. For instance, Medicare provides coverage for a 3-month trial of CPAP devices and accessories for individuals diagnosed with obstructive sleep apnea.
The incidence of sleep apnea and other respiratory disorders is on the rise in the U.S., primarily due to factors such as obesity, sedentary lifestyles, and an aging population. According to the Centers for Disease Control and Prevention (CDC) estimates published in May 2024, between August 2021 and August 2023, the obesity rate among adults was 40.3%, with no notable differences between women & men. Obesity was higher in adults aged 41-60 compared to those aged 20-39 and those 60 and older. This growing obesity rate contributes significantly to the increasing prevalence of sleep apnea, thereby driving the demand for CPAP devices.
Continuous innovations in CPAP technology have significantly enhanced patient comfort and therapy effectiveness. Modern CPAP machines feature quieter motors, compact designs, integrated humidification systems, and advanced data-tracking capabilities. These improvements address common patient concerns, such as noise and discomfort, leading to higher therapy adherence rates.
Government health agencies and non-profit organizations frequently conduct public awareness initiatives to inform individuals about sleep apnea and treatment needs. For instance, in May 2024, in the U.S., the CDC incorporated sleep apnea into its broader public health campaigns on sleep hygiene and the management of chronic diseases.
Market Concentration & Characteristics
The degree of innovation in the industry is high due to the rising investments in research and development are anticipated to drive market growth and support ongoing innovation in the sector. For instance, in March 2024, React Health launched the Luna TravelPAP, a compact and lightweight positive airway pressure device designed for travel. It offers a pressure range of 4 to 20 hPa, a ramp time adjustable from 0 to 60 minutes, and runs at a noise level below 30 dBA, ensuring quiet and convenient therapy.
The M&A activities in the U.S. market are medium. Companies engage in M&A to strengthen their product portfolios, expand their market reach, and integrate new technologies. For instance, in July 2023, ResMed acquired Somnoware, a company that develops sleep and respiratory diagnostics software.
“We’re committed to driving wider adoption of Somnoware’s open and interoperable platform to help more people with [obstructive sleep apnea] or COPD get the diagnoses and treatment solutions they need. Improving patients’ experience and health outcomes is our common goal.”
- Lucile Blaise, president of ResMed’s sleep and respiratory care division.
The impact of regulations on the U.S. market is high. The FDA's stringent approval processes for medical devices directly influence the introduction of new products and market access. Reimbursement policies by government and private insurers significantly affect adoption rates. Increased focus on regulating sleep disorders and implementing policies to ensure device efficacy and patient safety are shaping market dynamics.
Product expansion in the U.S. market is medium, with companies introducing new products to meet diverse patient needs. Such innovation highlights the company's commitment to advancing solutions for individuals with sleep-related breathing disorders.
Connectivity Insights
Connected CPAP devices held the largest revenue share of 68.83% in 2024 and are anticipated to grow at the fastest CAGR over the forecast period. Integrating Bluetooth, Wi-Fi, and cellular connectivity features in CPAP devices allows seamless data transmission between patients and healthcare providers, enhancing therapy adherence and effectiveness. For instance, ResMed's AirSense 10 and 11 models offer advanced connectivity and mobile health features, leading the market in this segment. This trend aligns with the broader digital transformation in healthcare, emphasizing data-driven care and patient empowerment.
The non-connected devices segment is anticipated to grow at a significant CAGR over the forecast period. This segment is driven by demand from tech-averse users, older adults, and individuals in rural areas with limited internet access. Cost-effectiveness and simplicity are key drivers, as these devices are typically more affordable and easier to use than connected alternatives. They appeal to budget-conscious consumers seeking reliable, no-frills treatment for sleep apnea.
End-use Insights
The home care settings segment held the largest revenue share in 2024 and is anticipated to grow at the fastest CAGR during the forecast period due to increasing preference for at-home treatment of sleep apnea and the growing aging population. Patients and healthcare providers favor home-based CPAP therapy for its convenience, cost-effectiveness, and ability to improve adherence. Advancements in portable and user-friendly CPAP devices have increased adoption in residential settings. In addition, the COVID-19 pandemic accelerated the shift toward home care as patients sought safer alternatives to hospital-based treatment for chronic respiratory conditions.
The hospitals & clinics segment is anticipated to grow significantly over the forecast period. These facilities are the first point of contact for patients undergoing sleep studies and receiving CPAP therapy prescriptions. Hospitals provide immediate access to trained professionals and diagnostic tools, ensuring proper device setup and monitoring. In addition, post-operative and critically ill patients with respiratory conditions rely on CPAP devices during recovery.
U.S. CPAP Market: Company-wise Market Value, ASP & Unit Volume Trends (2012-2024)
The U.S. CPAP market has witnessed dynamic shifts over the past decade, gradually moving toward consolidation. This trend has been primarily driven by competitive realignment, evolving consumer preferences, and advancements in sleep therapy technologies.
Key Observations: (Based on GVR Proprietary Database - Referenced and Cited by Notable Industry Players)
- ResMed
• Demonstrated the strongest growth trajectory across all players.
• Solidified its position as the market leader, especially after 2021, driven by product innovation and increased brand trust.
- Fisher & Paykel
• Maintained moderate, steady growth, with market value increasing from an analyzed USD 26.8 million in 2012 to USD 105.7 million by 2024.
• Benefited from rising demand for non-invasive ventilation and sleep therapy solutions, supporting its expanding U.S. footprint.
- React Health (3B Medical)
• A smaller but steadily growing market player, with a compound annual growth rate (CAGR) of ~0.07%.
• Gained traction following Philips’ market exit, meeting demand from DME (durable medical equipment) providers seeking alternative device suppliers.
- Philips
• Formerly a leading player in the U.S. CPAP market.
• Experienced a decline post-2016, followed by a complete market exit after 2021 due to widespread product recalls, resulting in a loss of market share and brand trust.
Market Dynamics Driving Long-Term Growth
Rising prevalence of sleep apnea and increased diagnosis rates
Integration of telehealth and remote monitoring capabilities
Shift toward home-based respiratory care and portable CPAP systems
Loss of consumer trust in legacy brands post-recalls, reshuffling loyalty
Note for viewer: Detailed insights for each notable player from 2012 to 2024, including Annual Market Value, Average Selling Price (ASP), and Unit Volume, are part of the final deliverables prepared by the analyst team at the individual company level.
Strategies of Market Players for Entry and Exit and Their Impact on Market Competitors
1. Medical Depot, Inc. Dba Drive Devilbiss Healthcare:
Medical Depot, Inc. Dba Drive Devilbiss Healthcare’s Exit Strategy Aims To Realign The Company With Its Mission And Vision
In September 2021, Medical Depot, Inc. dba Drive DeVilbiss Healthcare, announced its decision to discontinue its CPAP devices.
The company decided to shift its focus toward its market-leading oxygen products. This strategic move allowed the company to optimize its resources and manufacturing capacity to meet the heightened demand for oxygen therapy devices during the pandemic.
Following an extensive review process lasting almost a year, the decision demonstrates the company’s acknowledgment of unfavorable market conditions
In accordance with the insights from secondary research, Drive DeVilbiss Healthcare has pivoted its mission focus toward the following key product lines:
2. Entry of React Health following Medical Depot, Inc. dba Drive DeVilbiss Healthcare’s exit and its anticipated impact:
The acquisition of Medical Depot, Inc. dba Drive DeVilbiss Healthcare’s IntelliPAP line of CPAP devices assets by React Health is likely to have significant implications for the CPAP devices market, including changes in competition, product availability, market dynamics, customer support, etc.
Analyst Insight: These additions to React Health’s portfolio broaden its offerings for sleep care, catering to various patient needs and providing comprehensive solutions for end-to-end patient care in the sleep space.
Note for viewer: Complete insights around the exit strategies will be provided in the final deliverable
Key U.S. Continuous Positive Airway Pressure Devices Companies:
- ResMed
- Koninklijke Philips N.V.
- Fisher & Paykel Healthcare Limited
- React Health (3B Medical)
- Löwenstein Medical
- BMC Medical
- Wellell (Apex Medical)
- Armstrong Medical
- Breas Medical
- SEFAM
- Smiths Group PLC
- Transcend Inc. (Somnetics International, Inc.)
- Trudell Medical (Vyaire)
- Medical Depot, Inc. dba Drive DeVilbiss Healthcare
- Invacare Corporation
Recent Developments
In September 2024, ResMed's launch of the AirTouch N30i, a thoroughly fabric sleep apnea mask, exemplifies the industry's commitment to integrating advanced technology with user comfort.
“As a global leader in sleep health and CPAP therapy, millions of people trust ResMed’s devices to help them sleep better and live healthier lives. We are excited to introduce the AirTouch N30i, a mask that redefines comfort with its soft, natural feel and sleek, modern design. It sets a new standard in CPAP masks, helping more people stay committed to their therapy and achieve better sleep while offering a refined aesthetic that is as pleasing to look at as it is to wear.”
- Justin Leong, ResMed chief product officer.
U.S. Continuous Positive Airway Pressure Devices Market Report Scope
Report Attribute | Details |
Revenue Forecast in 2025 | USD 660.68 million |
Revenue Forecast in 2030 | USD 820.85 million |
Growth rate | CAGR of 4.44% from 2025 to 2030 |
Actual data | 2012 - 2024 (USD Million, 000' Units) |
Forecast data | 2025 - 2030 (USD Million, 000' Units) |
Quantitative units | Volume in 000' Units; revenue in USD million/billion, ASP Trend and CAGR from 2025 to 2030 |
Report Coverage | Revenue & volume forecast, company ranking, competitive landscape, growth factors, and trends |
Segments Covered | Connectivity, end-use |
Key companies profiled | ResMed; Koninklijke Philips N.V.; Fisher & Paykel Healthcare Limited; React Health (3B Medical); Löwenstein Medical; BMC Medical; Wellell (Apex Medical); Armstrong Medical; Breas Medical; SEFAM; Smiths Group PLC; Transcend Inc. (Somnetics International, Inc.); Trudell Medical (Vyaire); Medical Depot, Inc. dba Drive DeVilbiss Healthcare; Invacare Corporation; Others |
Customization scope | Free report customization (equivalent to up to 8 analyst’s working days) with purchase. Addition or alteration to country & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs.Explore purchase options |
U.S. Continuous Positive Airway Pressure Devices Market Report Segmentation
This report forecasts revenue & volume growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. continuous positive airway pressure devices market report based on connectivity and end-use:
Connectivity Outlook (Volume, 000' Units; Revenue, USD Million, 2018 - 2030)
Connected
Bluetooth-Connected CPAP
Wi-Fi & Cellular Connected CPAP
Hybrid-Connected
Non-Connected
End-use Outlook (Volume, 000' Units; Revenue, USD Million, 2018 - 2030)
Home Care Settings
Hospitals & Clinics
Others (Long-Term Care Facilities, etc.)
Frequently Asked Questions About This Report
How big is the U.S. continuous positive airway pressure devices market?
b. The U.S. continuous positive airway pressure devices market size was estimated at USD 632.10 million in 2024 and is expected to reach USD 660.68 million in 2025.
What is the U.S. continuous positive airway pressure devices market growth?
b. The U.S. continuous positive airway pressure devices market is expected to grow at a compound annual growth rate of 4.44% from 2025 to 2030 to reach USD 820.85 million by 2030.
Which segment accounted for the largest U.S. Continuous Positive Airway Pressure (CPAP) Devices market share?
b. The connected CPAP devices segment held the largest revenue share of over 68.83% in 2024 and is anticipated to grow at the fastest growth rate over the forecast year. Integrating Bluetooth, Wi-Fi, and cellular connectivity features in CPAP devices allows seamless data transmission between patients and healthcare providers, enhancing therapy adherence and effectiveness.
Who are the key players in U.S. continuous positive airway pressure devices market?
b. Some key players operating in the U.S. CPAP devices market include ResMed, Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited, Medical Depot, Inc. dba Drive DeVilbiss Healthcare, React Health (3B Medical), Transcend Inc. (Somnetics International, Inc.), Wellell Inc. (Apex Medical), Invacare Corporation, CONMED Corporation
What are the factors driving the U.S. continuous positive airway pressure devices market?
b. Key factors that are driving the market growth include the rising prevalence of sleep apnea and respiratory disorders, technological advancements in CPAP devices, growing awareness and diagnosis of sleep apnea, and favorable reimbursement policies.